Last month's U.S. Supreme Court decision in Association for Molecular Pathology v. Myriad Genetics, which considered whether portions of human genes may be patented, generated an extraordinary amount of passion for an intellectual property case.
James Watson, the Nobel Laureate credited with discovery of the double helix structure of DNA, wrote an amicus brief opining that human genes should not be patented: "Life's instructions ought not be controlled by legal monopolies created at the whim of Congress or the courts."
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
